{
    "title": "Down syndrome people have even lower D levels if have additional Vitamin D diseases",
    "slug": "down-syndrome-people-have-even-lower-d-levels-if-have-additional-vitamin-d-diseases",
    "aliases": [
        "/Down+syndrome+people+have+even+lower+D+levels+if+have+additional+Vitamin+D+diseases+\u2013+Oct+2023",
        "/14783"
    ],
    "tiki_page_id": 14783,
    "date": "2023-10-26",
    "categories": [
        "Health Problem",
        "Autism"
    ],
    "tags": [
        "Autism",
        "Health Problem",
        "autoimmune",
        "blood levels",
        "bone",
        "brain",
        "breathing",
        "child",
        "childhood obesity",
        "cognitive",
        "cystic fibrosis",
        "dermatology",
        "diabetes",
        "diabetes and vitamin d receptor",
        "down syndrome",
        "genetics",
        "hair",
        "health risk",
        "high dose",
        "immunity",
        "intervention",
        "metabolic",
        "multiple sclerosis",
        "obesity",
        "obesity and vitamin d receptor",
        "omega 3",
        "pediatric autoimmune",
        "rickets",
        "therapeutic intervention",
        "type 1 diabetes",
        "vitamin d",
        "vitamin d blood test",
        "vitamin d receptor"
    ]
}


{{< toc >}}

---

#### Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder

J Neurodev Disord . 2023 Oct 25;15(1):35. [doi: 10.1186/s11689-023-09503-y.](https://doi.org/10.1186/s11689-023-09503-y.)

Natalie K Boyd 1, Julia Nguyen 2, Mellad M Khoshnood 1, Timothy Jiang 1, Lina Nguyen 1, Lorena Mendez 1, Noemi A Spinazzi 3, Melanie A Manning 4, Michael S Rafii 5 6, Jonathan D Santoro 7 8

Background: Plasma levels of vitamin D have been reported to be low in persons with Down syndrome (DS) and existing data is limited to small and homogenous cohorts. This is of particular importance in persons with DS given the high rates of autoimmune disease in this population and the known relationship between vitamin D and immune function. This study sought to investigate vitamin D status in a multi-center cohort of individuals with DS and compare them to individuals with autism spectrum disorder (ASD) and neurotypical (NT) controls.

Methods: A retrospective, multi-center review was performed. The three sites were located at latitudes of 42.361145, 37.44466, and 34.05349. Patients were identified by the International Classification of Diseases (ICD)-9 or ICD-10 codes for DS, ASD, or well-child check visits for NT individuals. The first vitamin D 25-OH level recorded in the electronic medical record (EMR) was used in this study as it was felt to be the most reflective of a natural and non-supplemented state. Vitamin D 25-OH levels below 30 ng/mL were considered deficient.

Results: In total, 1624 individuals with DS, 5208 with ASD, and 30,775 NT controls were identified. 

* Individuals with DS had the lowest mean level of vitamin D 25-OH at 20.67 ng/mL, 

* compared to those with ASD (23.48 ng/mL) and 

* NT controls (29.20 ng/mL) (p < 0.001, 95% CI: -8.97 to -6.44).

A total of 399 (24.6%) individuals with DS were considered vitamin D deficient compared to 1472 (28.3%) with ASD and 12,397 (40.3%) NT controls (p < 0.001, 95% CI: -5.43 to -2.36). Individuals with DS with higher body mass index (BMI) were found to be more likely to have lower levels of vitamin D (p < 0.001, 95% CI: -0.3849 to -0.1509). 

Additionally, having both DS and a neurologic diagnosis increased the likelihood of having lower vitamin D levels (p < 0.001, 95% CI: -5.02 to -1.28).

Individuals with DS and autoimmune disease were much more likely to have lower vitamin D levels (p < 0.001, 95% CI: -6.22 to -1.55). 

Similarly, a history of autoimmunity in a first-degree relative also increased the likelihood of having lower levels of vitamin D in persons with DS (p = 0.01, 95% CI: -2.45 to -0.63).

Conclusions: Individuals with DS were noted to have hypovitaminosis D in comparison to individuals with ASD and NT controls. Associations between vitamin D deficiency and high BMI, personal autoimmunity, and familial autoimmunity were present in individuals with DS.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/down-2023-compresspdf.pdf">Download the PDF from VitaminDWiki </a>** 

---

##### 60 References

1. de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with  **Down**  syndrome in the United States. Am J Med Genet A. 2015;167a(4):756–67. - PubMed - DOI

1. de Graaf G, Buckley F, Skotko BG. Live births, natural losses, and elective terminations with  **Down**  syndrome in Massachusetts. Genet Med. 2016;18(5):459–66. - PubMed - DOI

1. Chicoine B, Rivelli A, Fitzpatrick V, Chicoine L, Jia G, Rzhetsky A.  **Prevalence of common disease conditions in a large cohort of individuals with Down syndrome**  in the United States. J Patient Cent Res Rev. 2021;8(2):86–97. - PubMed - PMC - DOI

1. Startin CM, D’Souza H, Ball G, Hamburg S, Hithersay R, Hughes KMO, et al.  **Health comorbidities and cognitive abilities**  across the lifespan in  **Down**  syndrome. J Neurodev Disord. 2020;12(1):4. - PubMed - PMC - DOI

1. Stagi S, Lapi E, Romano S, Bargiacchi S, Brambilla A, Giglio S, et al. Determinants of vitamin D levels in children and adolescents with  **Down**  syndrome. Int J Endocrinol. 2015;2015:896758. - PubMed - PMC - DOI

1. Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with  **Down**  syndrome. Eur J Intern Med. 2015;26(6):385–91. - PubMed - DOI

1. Zubillaga P, Garrido A, Mugica I, Ansa J, Zabalza R, Emparanza JI. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with  **Down** ’s syndrome. Eur J Clin Nutr. 2006;60(5):605–9. - PubMed - DOI

1. Nodehi M, Ajami A, Izad M, Asgarian Omran H, Chahardoli R, Amouzegar A, et al. Effects of vitamin D supplements on frequency of CD4(+) T-cell subsets in women with Hashimoto’s thyroiditis: a double-blind placebo-controlled study. Eur J Clin Nutr. 2019;73(9):1236–43. - PubMed - DOI

1. Zhao R, Zhang W, Ma C, Zhao Y, Xiong R, Wang H, et al. Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front Immunol. 2021;12:574967. - PubMed - PMC - DOI

1. Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation. 2015;22(6):400–4. - PubMed - DOI

1. Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. - PubMed - PMC - DOI

1. Altun H, Kurutaş EB, Şahin N, Güngör O, Fındıklı E. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with  **Autism**  spectrum disorders. Clin Psychopharmacol Neurosci. 2018;16(4):383–90. - PubMed - PMC - DOI

1. Molloy CA, Kalkwarf HJ, Manning-Courtney P, Mills JL, Hediger ML. Plasma 25(OH)D concentration in children with  **Autism**  spectrum disorder. Dev Med Child Neurol. 2010;52(10):969–71. - PubMed - PMC - DOI

1. Esnafoglu E, Subaşı B. Association of low 25-OH-vitamin D levels and peripheral inflammatory markers in patients with  **Autism**  spectrum disorder: vitamin D and inflammation in  **Autism** . Psychiatry Res. 2022;316:114735. - PubMed - DOI

1. Zhang M, Wu Y, Lu Z, Song M, Huang X, Mi L, et al. Effects of vitamin D supplementation on children with  **Autism**  spectrum disorder: a systematic review and meta-analysis. Clin Psychopharmacol Neurosci. 2023;21(2):240–51. - PubMed - PMC - DOI

1. Li B, Xu Y, Zhang X, Zhang L, Wu Y, Wang X, et al. The effect of vitamin D supplementation in treatment of children with  **Autism**  spectrum disorder: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2022;25(4):835–45. - PubMed - DOI

1. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–52. - PubMed - DOI

1. Petruzzelli MG, Marzulli L, Margari F, De Giacomo A, Gabellone A, Giannico OV, et al. Vitamin D deficiency in  **Autism**  spectrum disorder: a cross-sectional study. Dis Markers. 2020;2020:9292560. - PubMed - PMC - DOI

1. Şengenç E, Kıykım E, Saltik S. Vitamin D levels in children and adolescents with  **Autism** . J Int Med Res. 2020;48(7):300060520934638. - PubMed - DOI

1. Arastoo AA, Khojastehkia H, Rahimi Z, Khafaie MA, Hosseini SA, Mansouri MT, et al. Evaluation of serum 25-hydroxy vitamin D levels in children with  **Autism**  spectrum disorder. Ital J Pediatr. 2018;44(1):150. - PubMed - PMC - DOI

1. Corder JP, Al Ahbabi FJS, Al Dhaheri HS, Chedid F. Demographics and co-occurring conditions in a clinic-based cohort with  **Down**  syndrome in the United Arab Emirates. Am J Med Genet A. 2017;173(9):2395–407. - PubMed - DOI

1. Santoro JD, Partridge R, Tanna R, Pagarkar D, Khoshnood M, Rehmani M, et al. Evidence of neuroinflammation and immunotherapy responsiveness in individuals with  **Down**  syndrome regression disorder. J Neurodev Disord. 2022;14(1):35. - PubMed - PMC - DOI

1. Santoro SL, Baumer NT, Cornacchia M, Franklin C, Hart SJ, Haugen K, et al. Unexplained regression in  **Down**  syndrome: management of 51 patients in an international patient database. Am J Med Genet A. 2022;188(10):3049–62.

1. Santoro SL, Cannon S, Capone G, Franklin C, Hart SJ, Hobensack V, et al. Unexplained regression in  **Down**  syndrome: 35 cases from an international  **Down**  syndrome database. Genet Med. 2020;22(4):767–76. - PubMed - DOI

1. Santoro JD, Lee S, Wang AC, Ho E, Nagesh D, Khoshnood M, et al. Increased autoimmunity in individuals with  **Down**  syndrome and moyamoya disease. Front Neurol. 2021;12:724969. - PubMed - PMC - DOI

1. Goksin S. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. North Clin Istanb. 2022;9(5):451–8. - PubMed - PMC

1. Sassi F, Tamone C, D’Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018;10(11):1656. https://pubmed.ncbi.nlm.nih.gov/30400332/

1. Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061–94. - PubMed - DOI

1. Prietl B, Treiber G, Mader JK, Hoeller E, Wolf M, Pilz S, et al. High-dose cholecalciferol supplementation significantly increases peripheral CD4+ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr. 2014;53(3):751–9. - PubMed - DOI

1. Bock G, Prietl B, Mader JK, Höller E, Wolf M, Pilz S, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27(8):942–5. - PubMed - DOI

1. Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - a randomized clinical trial. Clin Immunol. 2015;161(2):217–24. - PubMed - DOI

1. Cao B, Wen T, Wei M, Xiong Y, Liu W, Zhu L, et al. Transcriptomic analysis reveal the responses of dendritic cells to VDBP. Genes Genomics. 2022;44(10):1271–82. - PubMed - DOI

1. Navarro-Barriuso J, Mansilla MJ, Quirant-Sánchez B, Teniente-Serra A, Ramo-Tello C, Martínez-Cáceres EM. Vitamin D3-induced tolerogenic dendritic cells modulate the transcriptomic profile of T CD4(+) cells towards a functional hyporesponsiveness. Front Immunol. 2020;11:599623. - PubMed - DOI

1. Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, et al. Analysis of the seasonal fluctuation of γδ T cells and its potential relation with vitamin D(3). Cells. 2022;11(9).

1. Sheikh V, Kasapoglu P, Zamani A, Basiri Z, Tahamoli-Roudsari A, Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells,  **Down** regulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum Immunol. 2018;79(6):439–45. - PubMed - DOI

1. Siracusano M, Riccioni A, Abate R, Benvenuto A, Curatolo P, Mazzone L. Vitamin D deficiency and  **Autism**  spectrum disorder. Curr Pharm Des. 2020;26(21):2460–74. - PubMed - DOI

1. Galoppin M, Kari S, Soldati S, Pal A, Rival M, Engelhardt B, et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Commun. 2022;4(4):fcac171. - PubMed - PMC - DOI

1. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36. - PubMed - DOI

1. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45(2):256–66. - PubMed - DOI

1. Spinazzi NA, Santoro JD, Pawlowski K, Anzueto G, Howe YJ, Patel LR, et al. Co-occurring conditions in children with  **Down**  syndrome and  **Autism** : a retrospective study. J Neurodev Disord. 2023;15(1):9. - PubMed - PMC - DOI

1. Ferrari M, Stagi S. Autoimmunity and genetic syndromes: a focus on  **Down**  syndrome. Genes (Basel). 2021;12(2).

1. Taksler GB, Cutler DM, Giovannucci E, Keating NL. Vitamin D deficiency in minority populations. Public Health Nutr. 2015;18(3):379–91. - PubMed - DOI

1. Kumaratne M, Early G, Cisneros J. Vitamin D deficiency and association with body mass index and lipid levels in Hispanic American adolescents. Glob Pediatr Health. 2017;4:2333794x17744141. - PubMed - PMC

1. Talib HJ, Ponnapakkam T, Gensure R, Cohen HW, Coupey SM. Treatment of vitamin D deficiency in predominantly Hispanic and Black adolescents: a randomized clinical trial. J Pediatr. 2016;170:266-72.e1. - PubMed - DOI

1. Muscogiuri G, Barrea L, Somma CD, Laudisio D, Salzano C, Pugliese G, et al. Sex differences of vitamin D status across BMI classes: an observational prospective cohort study. Nutrients. 2019;11(12).

1. Oreskovic NM, Baumer NT, Di Camillo C, Cornachia M, Franklin C, Hart SJ, et al. Cardiometabolic profiles in children and adults with overweight and obesity and  **Down**  syndrome. Am J Med Genet A. 2023;191(3):813–22. - PubMed - DOI

1. Bandini LG, Fleming RK, Scampini R, Gleason J, Must A. Is body mass index a useful measure of excess body fatness in adolescents and young adults with  **Down**  syndrome? J Intellect Disabil Res. 2013;57(11):1050–7. - PubMed - DOI

1. De Pergola G, Martino T, Zupo R, Caccavo D, Pecorella C, Paradiso S, et al. 25 Hydroxyvitamin D levels are negatively and independently associated with fat mass in a cohort of healthy overweight and obese subjects. Endocr Metab Immune Disord Drug Targets. 2019;19(6):838–44. - PubMed - PMC - DOI

1. Heller JE, Thomas JJ, Hollis BW, Larson-Meyer DE. Relation between vitamin D status and body composition in collegiate athletes. Int J Sport Nutr Exerc Metab. 2015;25(2):128–35. - PubMed - DOI

1. Ross CF, Bernhard CB, Smith-Simpson S. Parent-reported ease of eating foods of different textures in young children with  **Down**  syndrome. J Texture Stud. 2019;50(5):426–33. - PubMed - DOI

1. Serel Arslan S. Swallowing related problems of toddlers with  **Down**  syndrome. J Dev Phys Disabil. 2022:1–11. https://pubmed.ncbi.nlm.nih.gov/36118664/ .

1. Ross CF, Bernhard CB, Surette V, Hasted A, Wakeling I, Smith-Simpson S. Eating behaviors in children with  **Down**  syndrome: results of a home-use test. J Texture Stud. 2022;53(5):629–46. - PubMed - DOI

1. Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, et al. Vitamin D supplementation is beneficial for children with  **Autism**  spectrum disorder: a meta-analysis. Clin Psychopharmacol Neurosci. 2020;18(2):203–13. - PubMed - PMC - DOI

1. Feng J, Shan L, Du L, Wang B, Li H, Wang W, et al. Clinical improvement following vitamin D3 supplementation in  **Autism**  spectrum disorder. Nutr Neurosci. 2017;20(5):284–90. - PubMed - DOI

1. Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, et al. Vitamin D status in  **Autism**  spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2016;19(8):346–51. - PubMed - DOI

1. Kerley CP, Power C, Gallagher L, Coghlan D. Lack of effect of vitamin D(3) supplementation in  **Autism** : a 20-week, placebo-controlled RCT. Arch Dis Child. 2017;102(11):1030–6. - PubMed - DOI

1. Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep. 2017;7(1):14818. - PubMed - PMC - DOI

1. Hisbiyah Y, Endaryanto A, Setyoboedi B, Rochmah N, Faizi M. The correlation between vitamin D and levels of IFN-γ, NF-κB, thyroid antibodies in  **Down**  syndrome: study in Indonesian children. Acta Biomed. 2022;93(6):e2022342. - PubMed - PMC

1. Ragab D, Soliman D, Samaha D, Yassin A. Vitamin D status and its modulatory effect on interferon gamma and interleukin-10 production by peripheral blood mononuclear cells in culture. Cytokine. 2016;85:5–10. - PubMed - DOI

1. Izquierdo-Gomez R, Martínez-Gómez D, Acha A, Veiga OL, Villagra A, Diaz-Cueto M. Objective assessment of sedentary time and physical activity throughout the week in adolescents with  **Down**  syndrome The UP&Down study. Res Dev Disabil. 2014;35(2):482–9. - PubMed - DOI

1. Esposito PE, MacDonald M, Hornyak JE, Ulrich DA. Physical activity patterns of youth with  **Down**  syndrome. Intellect Dev Disabil. 2012;50(2):109–19. - PubMed - DOI